Bay Street News, September 4th, 2020

SAN DIEGO, Sept. 04, 2020 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on […]

Stéphane Therrien, Interim President and Chief Executive Officer, commented on the third quarter of 2020 highlights: “From the onset of […]

HOUSTON, Sept. 04, 2020 (GLOBE NEWSWIRE) — Archrock, Inc. (NYSE:AROC) (“Archrock”) today announced that Brad Childers, President and Chief Executive […]

COPENHAGEN, Denmark, Sept. 04, 2020 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative […]

LEXINGTON, Mass., Sept. 04, 2020 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, […]

WOBURN, Mass., Sept. 04, 2020 (GLOBE NEWSWIRE) — NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it will present a scientific poster […]

SOUTH SAN FRANCISCO, Calif., Sept. 04, 2020 (GLOBE NEWSWIRE) — Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused […]

NEW HAVEN, Conn., Sept. 04, 2020 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new […]

CAMBRIDGE, Mass., Sept. 04, 2020 (GLOBE NEWSWIRE) — Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company focused on the […]

SUNNYVALE, Calif., Sept. 04, 2020 (GLOBE NEWSWIRE) — eGain (NASDAQ: EGAN), a leading provider of cloud customer engagement solutions, today announced […]